Gastroenterology and Hepatology Neoplasia Fellowship (Minnesota) – Residencies and Fellowships – Mayo Clinic College of Medicine & Science
Mayo Clinic offers the Gastroenterology and Hepatology Neoplasia Fellowship in Rochester, Minnesota.
Related Articles
Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn’s disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials
Intravenous induction followed by subcutaneous maintenance therapy with guselkumab was efficacious in participants with moderately to severely active Crohn’s disease, showing superiority to placebo and…
Decoding intestinal metaplasia: a step towards understanding gastric tumourigenesis
Tissue epithelia maintain their lineage identity under normal conditions but occasionally undergo ‘reprogramming’ into another lineage—a phenomenon known as metaplasia. Notable examples include intestinal metaplasia…
GPR171 restrains intestinal inflammation by suppressing FABP5-mediated Th17 cell differentiation and lipid metabolism
Background GPR171 suppresses T cell immune responses involved in antitumour immunity, while its role in inflammatory bowel disease (IBD) pathogenesis remains unclear. Objective We aimed…
Heterogeneity and plasticity of cholangiocytes in liver injury: a journey from pathophysiology to therapeutic utility
Cholangiocytes are highly specialised cells participating in the pathobiology of various liver diseases and recognised to play a crucial role in response to liver injury.…
Tumour-intrinsic alterations and stromal matrix remodelling promote Wnt-niche independence during diffuse-type gastric cancer progression
Background Development of diffuse-type gastric cancer (DGC) starts with intramucosal lesions that are primarily composed of differentiated, non-proliferative signet ring cells (SRCs). These indolent lesions…
Bioprinting functional hepatocyte organoids derived from human chemically induced pluripotent stem cells to treat liver failure
Background To treat liver failure, three-dimensional (3D) bioprinting is a promising technology used to construct hepatic tissue models. However, current research on bioprinting of hepatic…
Success of different closure modalities of gastrogastric or jejunal-gastric fistulas after EUS-directed transgastric intervention
EUS-directed transgastric intervention (EDGI) involves the creation of a temporary tract between the gastric pouch or proximal jejunum and excluded stomach by deploying a lumen-apposing…
Transfusion Timing Crucial in Patients With UGI Bleeding
In patients with upper GI bleeding, early blood product transfusion is independently associated with improved clinical outcomes.
Meeting Home Page
Displays details of a selected meeting including Date, Time, location, and additional content.
IBS in IBD Patients: Prevalence & Treatment – July 2025
Understand IBS prevalence (~39‑44%) in IBD patients in remission, its gut–brain axis and microbiota–driven etiology, and tailored treatment strategies.
